ArticleCancers2021

Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments.

Cinzia Vetrei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.